2NA FISH GmbH

Located in Munich, Germany, 2NA FISH GmbH specializes in biotechnology, focusing on advanced bioinformatics solutions that enhance genomic analysis and streamline research processes across various sectors including agriculture and personalized medicine. Founded in 2024, 2NA FISH GmbH operates from Munich, Germany, developing innovative bioinformatics tools for genetic research. In January 2026, 2NA FISH GmbH raised an undisclosed amount of pre-seed funding ledbyGrunderfonds Ruhr and TWIP Impact Ventures. 2nafish.

bio specializes in innovative solutions within the biotechnology sector, focusing primarily on the development of advanced bioinformatics tools and platforms. Their core offerings aim to enhance genomic analysis and streamline research processes for various applications, including agricultural biotechnology and personalized medicine. By providing robust data analytics and visualization capabilities, 2nafish. bio enables researchers and organizations to derive actionable insights from complex biological data.

The company caters to a diverse clientele, including academic institutions, pharmaceutical companies, and agricultural firms, primarily across North America, Europe, and Asia. Their products are designed to address specific challenges in genetic research and product development, facilitating the translation of scientific discoveries into practical applications. The revenue model for 2nafish. bio is structured around a combination of subscription-based services and direct sales of proprietary software solutions.

Clients typically engage with the company through annual subscriptions that grant access to its bioinformatics platforms, along with support and updates. The company also collaborates with research institutions and corporate partners to provide tailored solutions that meet specific research needs, contributing further to its revenue streams. Flagship products in their portfolio, designed for high-performance genomic analysis, form the backbone of these transactions. These offerings reflect the company's commitment to delivering high-value tools that empower clients to enhance their research capabilities and accelerate innovation in the biotech field.

2NA FISH GmbH is poised for growth with the development of new bioinformatics products aimed at enhancing genomic analysis, slated for release in the upcoming year. The company plans to expand its market reach into Asia and North America by the end of 2025. Recent funding from TWIP Impact Ventures will be utilized to support product development and market expansion efforts.